New hope for cancer patients: better nausea control during treatment
NCT ID NCT07254416
Summary
This study tests which of two drug combinations works better at preventing nausea and vomiting in breast cancer patients receiving T-DXd therapy. 120 participants will receive either the standard anti-nausea treatment or an experimental combination over two treatment cycles. The goal is to find the most effective approach to manage these side effects and improve patients' quality of life during cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER PATIENTS TREATED WITH T-DXD are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.